Natco to raise Adcock Ingram stake to 49% for Rupees 1069 crores
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts more than Nifty Smallcap 250 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Natco Pharma board approved acquiring additional shares in South Africa's Adcock Ingram Holdings at about Rupees 5.89 per share, raising its stake from 35.75% to 49% for around Rupees 1,069 crores. Separately, board approved investing up to Rupees 1,400 crores in its South African wholly owned subsidiary. Adcock Ingram posted US dollar 423 million topline in 9 months to March 2026. Post deal, Natco will book 49% of Adcock Ingram's profit after tax, strengthening its Africa footprint.
Africa expansion with meaningful profit contribution; combined capital outlay of about Rupees 2,469 crores.